Cargando…
Pentafluoro‐3‐hydroxy‐pent‐2‐en‐1‐ones Potently Inhibit FNT‐Type Lactate Transporters from all Five Human‐Pathogenic Plasmodium Species
The protozoan parasite Plasmodium falciparum causes the most severe and prevailing form of malaria in sub‐Saharan Africa. Previously, we identified the plasmodial lactate transporter, PfFNT, a member of the microbial formate–nitrite transporter family, as a novel antimalarial drug target. With the p...
Autores principales: | Walloch, Philipp, Hansen, Christian, Priegann, Till, Schade, Dennis, Beitz, Eric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247949/ https://www.ncbi.nlm.nih.gov/pubmed/33336890 http://dx.doi.org/10.1002/cmdc.202000952 |
Ejemplares similares
-
The Plasmodium Lactate/H(+) Transporter PfFNT Is Essential and Druggable In Vivo
por: Davies, Heledd, et al.
Publicado: (2023) -
Discovery and Development of Inhibitors of the Plasmodial FNT-Type Lactate Transporter as Novel Antimalarials
por: Nerlich, Cornelius, et al.
Publicado: (2021) -
Substrate-analogous inhibitors exert antimalarial action by targeting the Plasmodium lactate transporter PfFNT at nanomolar scale
por: Golldack, André, et al.
Publicado: (2017) -
Cell-Free and Yeast-Based Production of the Malarial Lactate Transporter, PfFNT, Delivers Comparable Yield and Protein Quality
por: Hajek, Philipp, et al.
Publicado: (2019) -
The Malaria Parasite's Lactate Transporter PfFNT Is the Target of Antiplasmodial Compounds Identified in Whole Cell Phenotypic Screens
por: Hapuarachchi, Sanduni V., et al.
Publicado: (2017)